American Society Of Clinical Psychopharmacology Inc
American Society Of Clinical Psychopharmacology Inc maintains stable finances with growing assets and no reported officer compensation.
EIN: 133691286 · Brentwood, TN · NTEE: A20Z · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $2.2M |
| Total Expenses | $860K |
| Program Spending | 80% |
| Net Assets | $1.8M |
| Transparency Score | 85/100 |
Is American Society Of Clinical Psychopharmacology Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
American Society Of Clinical Psychopharmacology Inc directs 80% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About American Society Of Clinical Psychopharmacology Inc
American Society Of Clinical Psychopharmacology Inc (EIN: 133691286) is a nonprofit organization based in Brentwood, TN, classified under NTEE code A20Z. The organization reported total revenue of $2.2M and total assets of $2.2M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Society Of Clinical Psychopharmacology Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American Society Of Clinical Psychopharmacology Inc is a mid-size nonprofit that has been operating for 32 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 2.2%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $939K |
| Total Expenses | $860K |
| Surplus / Deficit | +$78K |
| Total Assets | $1.8M |
| Total Liabilities | $94K |
| Net Assets | $1.8M |
| Operating Margin | 8.3% |
| Debt-to-Asset Ratio | 5.1% |
| Months of Reserves | 25.7 months |
Financial Health Grade: A
In 2023, American Society Of Clinical Psychopharmacology Inc reported a surplus of $78K with revenue exceeding expenses, holds 25.7 months of operating reserves (strong position), has a debt-to-asset ratio of 5.1% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), American Society Of Clinical Psychopharmacology Inc's revenue has grown at a compound annual growth rate (CAGR) of 2.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +25.4% | +17.2% | +3.6% |
| 2022 | +23.2% | +42.7% | -5.1% |
| 2021 | -1.7% | +19.7% | +12.2% |
| 2020 | -29.9% | -47.3% | +19.1% |
| 2019 | -13.0% | +5.6% | +9.8% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1994 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American Society Of Clinical Psychopharmacology Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 15%
- programs: 80%
- fundraising: 5%
According to IRS 990 filings, American Society Of Clinical Psychopharmacology Inc allocates its expenses as follows: admin: 15%, programs: 80%, fundraising: 5%. With 80% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $78K, with revenue exceeding expenses.
- Debt-to-asset ratio: 5.1%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that the organization's officers are either unpaid volunteers or compensated through other means not categorized as officer compensation, which is a strong positive for resource allocation.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for American Society Of Clinical Psychopharmacology Inc:
- Consistent positive net income in most years, indicating financial stability (e.g., $78,142 surplus in 2023).
- Steady growth in assets from $801,096 in 2015 to $1,844,466 in 2023, demonstrating strong financial health.
- Zero reported officer compensation across all filings, suggesting a high dedication of resources to the mission.
- Low liabilities relative to assets, indicating a strong balance sheet and low financial risk.
- Regular and transparent IRS 990 filings, providing clear financial oversight.
Frequently Asked Questions about American Society Of Clinical Psychopharmacology Inc
Is American Society Of Clinical Psychopharmacology Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, American Society Of Clinical Psychopharmacology Inc (EIN: 133691286) appears legitimate. Mission Score: 85/100. 0 red flags identified, 5 strengths noted.
How does American Society Of Clinical Psychopharmacology Inc spend its money?
American Society Of Clinical Psychopharmacology Inc directs 80% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to American Society Of Clinical Psychopharmacology Inc tax-deductible?
American Society Of Clinical Psychopharmacology Inc is registered as a tax-exempt nonprofit (EIN: 133691286). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of American Society Of Clinical Psychopharmacology Inc's spending goes to programs?
American Society Of Clinical Psychopharmacology Inc directs 80% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does American Society Of Clinical Psychopharmacology Inc compare to similar nonprofits?
With a transparency score of 85/100 (Excellent), American Society Of Clinical Psychopharmacology Inc is above average for NTEE category A20Z nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is American Society Of Clinical Psychopharmacology Inc located?
American Society Of Clinical Psychopharmacology Inc is headquartered in Brentwood, Tennessee and files with the IRS under EIN 133691286. It is classified under NTEE code A20Z.
How many years of IRS 990 filings does American Society Of Clinical Psychopharmacology Inc have?
American Society Of Clinical Psychopharmacology Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $2.2M in total revenue.
Is American Society Of Clinical Psychopharmacology Inc a good charity?
Based on the provided financial data, the organization appears to be financially healthy, transparent with its filings, and demonstrates good stewardship by reporting 0% officer compensation. Its consistent asset growth and positive net income suggest effective management.
How has the organization's financial health changed over time?
The organization has shown consistent financial growth, with assets nearly doubling from $801,096 in 2015 to $1,844,466 in 2023. Revenue and expenses have fluctuated but generally show a positive net income, indicating stable operations.
What is the trend in revenue and expenses?
Revenue has fluctuated, peaking at $1,072,437 in 2017 and $1,013,471 in 2018, then dipping before recovering to $938,559 in 2023. Expenses have generally followed revenue, maintaining a positive margin in most years, demonstrating fiscal prudence.
Filing History
IRS 990 filing history for American Society Of Clinical Psychopharmacology Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), American Society Of Clinical Psychopharmacology Inc's revenue has grown by 29.9%, moving from $723K to $939K. Total assets increased by 424.5% over the same period, from $352K to $1.8M. Total functional expenses rose by 41.7%, from $607K to $860K. In its most recent filing year (2023), American Society Of Clinical Psychopharmacology Inc reported a surplus of $78K, with revenue exceeding expenses. The organization holds $94K in liabilities against $1.8M in assets (debt-to-asset ratio: 5.1%), resulting in net assets of $1.8M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $939K | $860K | $1.8M | $94K | — | — |
| 2022 | $748K | $734K | $1.8M | $114K | — | View 990 |
| 2021 | $607K | $515K | $1.9M | $106K | — | View 990 |
| 2020 | $618K | $430K | $1.7M | $102K | — | View 990 |
| 2019 | $881K | $816K | $1.4M | $78K | — | View 990 |
| 2018 | $1.0M | $772K | $1.3M | $96K | — | View 990 |
| 2017 | $1.1M | $828K | $1.1M | $102K | — | View 990 |
| 2016 | $806K | $772K | $809K | $92K | — | View 990 |
| 2015 | $772K | $804K | $801K | $122K | — | View 990 |
| 2014 | $776K | $753K | $862K | $146K | — | View 990 |
| 2013 | $756K | $692K | $793K | $99K | — | View 990 |
| 2012 | $912K | $602K | $657K | $28K | — | View 990 |
| 2011 | $723K | $607K | $352K | $33K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $939K, expenses of $860K, and assets of $1.8M (revenue +25.4% year-over-year).
- 2022: Revenue of $748K, expenses of $734K, and assets of $1.8M (revenue +23.2% year-over-year).
- 2021: Revenue of $607K, expenses of $515K, and assets of $1.9M (revenue -1.7% year-over-year).
- 2020: Revenue of $618K, expenses of $430K, and assets of $1.7M (revenue -29.9% year-over-year).
- 2019: Revenue of $881K, expenses of $816K, and assets of $1.4M (revenue -13.0% year-over-year).
- 2018: Revenue of $1.0M, expenses of $772K, and assets of $1.3M (revenue -5.5% year-over-year).
- 2017: Revenue of $1.1M, expenses of $828K, and assets of $1.1M (revenue +33.1% year-over-year).
- 2016: Revenue of $806K, expenses of $772K, and assets of $809K (revenue +4.4% year-over-year).
- 2015: Revenue of $772K, expenses of $804K, and assets of $801K (revenue -0.6% year-over-year).
- 2014: Revenue of $776K, expenses of $753K, and assets of $862K (revenue +2.6% year-over-year).
- 2013: Revenue of $756K, expenses of $692K, and assets of $793K (revenue -17.1% year-over-year).
- 2012: Revenue of $912K, expenses of $602K, and assets of $657K (revenue +26.2% year-over-year).
- 2011: Revenue of $723K, expenses of $607K, and assets of $352K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American Society Of Clinical Psychopharmacology Inc:
Data Sources and Methodology
This transparency report for American Society Of Clinical Psychopharmacology Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.